Janney Montgomery Scott LLC Dbv Technologies S.A. Transaction History

Janney Montgomery Scott LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$1.28 - $1.73 $2,757 - $3,726	-2,154 Reduced 8.38%	23,546 $40,000
Q3 2022 Oct 25, 2022	SELL	$1.77 - $2.76 $7,080 - $11,040	-4,000 Reduced 13.47%	25,700 $45,000
Q3 2021 Oct 29, 2021	SELL	$4.71 - $5.92 $9,420 - $11,840	-2,000 Reduced 6.31%	29,700 $146,000
Q1 2021 Apr 27, 2021	BUY	$2.75 - $6.57 $6,875 - $16,425	2,500 Added 8.56%	31,700 $169,000
Q4 2020 Jan 25, 2021	BUY	$1.38 - $3.01 $40,296 - $87,892	29,200 New	29,200 $77,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $95.8M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.